Literature DB >> 32588730

Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells.

Ying Li1, Shuang Lin2, Na An3.   

Abstract

Circular RNAs (circRNAs) correlate with cancer cell phenotypes. Particularly, circRNAs mediate the cancer process as microRNAs (miRNAs) sponges. This study was to ascertain the roles of hsa_circ_0009910 in phenotypic aspects of ovarian cancer cells. Mantel-Cox test was performed to analyze the correlation between hsa_circ_0009910 and survival outcomes of ovarian cancer. Minigene reporter was constructed and small interfering-RNA was designed for constructing hsa_circ_0009910-dysregulated and miR-145-upregulated cells identified by qRT-PCR. Proliferative and motile activities were monitored by CCK and Transwell. Western blot was applied for quantification of cyclin D1, CDK4, CDK6, MMP-2, MMP-9, IκBα, p65, Notch1, Hes1, and Hes5. miRNAs targets were predicted using a bioinformatics tool and confirmed using qRT-PCR and Dual-Luciferase reporter assay. Hsa_circ_0009910 was correlated with the poor prognosis of ovarian cancer patients. The ovarian cancer cell phenotypes were promoted by hsa_circ_0009910 while repressed by silencing hsa_circ_0009910. Hsa_circ_0009910 silence was responsible for the upregulation of the predicted miRNAs targets. Thereinto, miR-145 was confirmed as a miRNA target and negatively regulated by hsa_circ_0009910. miR-145 nullified the biological function of hsa_circ_0009910 in the proliferative and motile phenotypes, and the active status of NF-κB and Notch. Hsa_circ_0009910, representing unfavorable prognosis, induced proliferative and motile phenotypes by suppressing miR-145 in ovarian cancer cells.

Entities:  

Keywords:  Hsa_circ_0009910; microrna-145; motility; ovarian cancer; proliferation

Year:  2020        PMID: 32588730      PMCID: PMC7469526          DOI: 10.1080/15384101.2020.1731650

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer.

Authors:  Bo Li; Fei Xie; Fu-Xin Zheng; Guo-Song Jiang; Fu-Qing Zeng; Xing-Yuan Xiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

2.  CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression via microRNA-21 and microRNA-31.

Authors:  Yuan Yuan; Wei Liu; Yangmei Zhang; Youwei Zhang; Sanyuan Sun
Journal:  Biochem Biophys Res Commun       Date:  2018-06-23       Impact factor: 3.575

3.  miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.

Authors:  Tae Hoen Kim; Ji-Ye Song; Hyun Park; Ju-Yeon Jeong; A-Young Kwon; Jin Hyung Heo; Haeyoun Kang; Gwangil Kim; Hee Jung An
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

4.  MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

Authors:  Blanca Majem; Alfonso Parrilla; Carlos Jiménez; Leticia Suárez-Cabrera; Marta Barber; Andrea Marín; Josep Castellví; Gabriel Tamayo; Gema Moreno-Bueno; Jordi Ponce; Xavier Matias-Guiu; Francesc Alameda; Ignacio Romero; José Luis Sánchez; Asunción Pérez-Benavente; Sebastián Moran; Manel Esteller; Jaume Reventós; Marina Rigau; Antonio Gil-Moreno; Miguel F Segura; Anna Santamaría
Journal:  Oncogene       Date:  2019-07-05       Impact factor: 9.867

5.  Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.

Authors:  Éva Márton; János Lukács; András Penyige; Eszter Janka; Lídia Hegedüs; Beáta Soltész; Gábor Méhes; Róbert Póka; Bálint Nagy; Melinda Szilágyi
Journal:  J Biotechnol       Date:  2019-04-03       Impact factor: 3.307

6.  Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.

Authors:  D W Cramer; W R Welch
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

7.  Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system.

Authors:  R Chiaramonte; M Colombo; G Bulfamante; M Falleni; D Tosi; S Garavelli; D De Simone; E Vigolo; K Todoerti; A Neri; N Platonova
Journal:  Int J Biochem Cell Biol       Date:  2015-07-30       Impact factor: 5.085

8.  Upregulation of Circular RNA VPS13C-has-circ-001567 Promotes Ovarian Cancer Cell Proliferation and Invasion.

Authors:  Liuping Bao; Jianxin Zhong; Lijuan Pang
Journal:  Cancer Biother Radiopharm       Date:  2018-10-30       Impact factor: 3.099

9.  High-throughput data integration of RNA-miRNA-circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity.

Authors:  Florian Caiment; Stan Gaj; Sandra Claessen; Jos Kleinjans
Journal:  Nucleic Acids Res       Date:  2015-02-17       Impact factor: 16.971

10.  MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.

Authors:  Flavia Biamonte; Gianluca Santamaria; Alessandro Sacco; Francesca Marta Perrone; Annalisa Di Cello; Anna Martina Battaglia; Alessandro Salatino; Anna Di Vito; Ilenia Aversa; Roberta Venturella; Fulvio Zullo; Francesco Costanzo
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

View more
  9 in total

Review 1.  The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.

Authors:  Sajad Najafi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

2.  Three novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network.

Authors:  Lianghai Wang; Lisha Zhou; Jun Hou; Jin Meng; Ke Lin; Xiangwei Wu; Xueling Chen
Journal:  Cancer Cell Int       Date:  2021-01-22       Impact factor: 5.722

3.  Importance of Circ0009910 in colorectal cancer pathogenesis as a possible regulator of miR-145 and PEAK1.

Authors:  Sepideh Kadkhoda; Reza Taslimi; Farshid Noorbakhsh; Farzaneh Darbeheshti; Javad Tavakkoly Bazzaz; Soudeh Ghafouri-Fard; Abbas Shakoori
Journal:  World J Surg Oncol       Date:  2021-09-03       Impact factor: 2.754

4.  Role and Mechanism of circ_0058063/miR-635 Axis in the Malignant Phenotype of Multiple Myeloma RPMI8226 Cells.

Authors:  Xiaoya Li; Lingzhi Ding; Geyu Gu; Changjun Zheng; Chenshuai Pan; Qi Zheng; Ting Xiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-13       Impact factor: 2.629

5.  CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review.

Authors:  Zahra Foruzandeh; Fatemeh Zeinali-Sehrig; Kazem Nejati; Dara Rahmanpour; Fariba Pashazadeh; Farhad Seif; Mohammad Reza Alivand
Journal:  Cell Mol Biol Lett       Date:  2021-09-23       Impact factor: 5.787

Review 6.  Emerging role of circular RNAs in the pathogenesis of ovarian cancer.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Majid Samsami
Journal:  Cancer Cell Int       Date:  2022-04-29       Impact factor: 6.429

7.  CircRNF144B/miR-342-3p/FBXL11 axis reduced autophagy and promoted the progression of ovarian cancer by increasing the ubiquitination of Beclin-1.

Authors:  Wenting Song; Zhirui Zeng; Yilei Zhang; Haili Li; Huimin Cheng; Jun Wang; Fengrui Wu
Journal:  Cell Death Dis       Date:  2022-10-08       Impact factor: 9.685

Review 8.  The Biomarker and Therapeutic Potential of Circular Rnas in Schizophrenia.

Authors:  Artem Nedoluzhko; Natalia Gruzdeva; Fedor Sharko; Sergey Rastorguev; Natalia Zakharova; Georgy Kostyuk; Vadim Ushakov
Journal:  Cells       Date:  2020-10-04       Impact factor: 6.600

9.  Circ_0109046 Promotes the Progression of Endometrial Cancer via Regulating miR-136/HMGA2 Axis.

Authors:  Yanping Shi; Li Jia; Hongli Wen
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.